Cutibacterium acnes cellular macromolecules (C. acnes macromolecules)

Cutibacterium acnes cellular macromolecules represent the collective set of essential biological components within the Gram-positive bacterium C. acnes, which is a primary driver of acne vulgaris (StatPearls, 2023). These macromolecules include proteins, nucleic acids, and cell wall constituents that are vital for the bacterium's survival, replication, and pathogenicity within the pilosebaceous unit (ChEMBL, Target CHEMBL2366922). In the disease state, C. acnes metabolizes sebum into free fatty acids, triggering inflammatory responses and follicular hyperkeratosis (PubMed, PMID: 31279008). Therapeutic agents target these macromolecules through various mechanisms: antibiotics like clindamycin and tetracyclines inhibit protein synthesis by binding to ribosomal subunits, while oxidizing agents like benzoyl peroxide cause non-specific damage to bacterial proteins and DNA (PubChem, CID: 2907). Because C. acnes is a commensal organism, targeting its macromolecules requires a balance between reducing pathogenic overgrowth and maintaining a healthy skin microbiome (NIH, 2022). The emergence of resistant strains has made these macromolecules a focus for developing novel antimicrobial peptides and targeted therapies (Journal of Clinical and Aesthetic Dermatology, 2017).

Other names

Propionibacterium acnes cellular macromoleculesC. acnes bacterial componentsCutibacterium acnes proteins and nucleic acidsC. acnes cellular targets

Drugs targeting these macromolecules typically act by inhibiting bacterial protein synthesis through binding to the 30S or 50S ribosomal subunits, disrupting DNA replication via inhibition of DNA gyrase, or inducing non-specific oxidative damage to bacterial proteins, lipids, and DNA through the release of reactive oxygen species.